DRUG-INDUCED DELIRIUM - INCIDENCE, MANAGEMENT AND PREVENTION

Citation
Gl. Carter et al., DRUG-INDUCED DELIRIUM - INCIDENCE, MANAGEMENT AND PREVENTION, Drug safety, 15(4), 1996, pp. 291-301
Citations number
103
Categorie Soggetti
Toxicology,"Pharmacology & Pharmacy","Public, Environmental & Occupation Heath
Journal title
ISSN journal
01145916
Volume
15
Issue
4
Year of publication
1996
Pages
291 - 301
Database
ISI
SICI code
0114-5916(1996)15:4<291:DD-IMA>2.0.ZU;2-L
Abstract
Drugs may be the most frequent single cause of delirium, and very ofte n they are a critical element in a multifactorial aetiology. While del irium may be precipitated by virtually any drug, certain classes of dr ugs are more commonly implicated. Effective management of drug-induced delirium involves recognition, cessation or dosage reduction of the c ausative drug(s), and initiation of reorientation strategies and suppo rtive medical care. Specific 'antidotes' are appropriate in only a few limited cases. Drug treatment aimed at sedation should be introduced for specific indications, such as aggression, risk of harm to self or others, hallucinations, patient distress, and where compliance with th erapy or procedures is essential. Certain benzodiazepines (diazepam, l orazepam, midazolam) and/or haloperidol may be the most appropriate ch oices in these circumstances. Primary prevention requires the prescrip tion of alternative lower risk medications and the minimisation of pol ypharmacy. Secondary prevention may be achieved through improved recog nition of the condition.